Related Experiment Videos
Percutaneous transluminal balloon angioplasty in suprahepatic IVC obstruction--Budd-Chiari syndrome
1Dept of Radiology & Gastroenterology & GI Surgery, G. B. Pant Hospital, New Delhi.
Tropical Gastroenterology : Official Journal of the Digestive Diseases Foundation
|January 1, 1995
Insights
Transluminal angioplasty offers promising results for Budd-Chiari Syndrome caused by suprahepatic inferior vena cava obstruction. Balloon dilatation provided significant clinical improvements and disease control in two treated patients.
Area of Science:
- Interventional Cardiology
- Hepatology
- Vascular Surgery
Background:
- Budd-Chiari Syndrome (BCS) can result from obstruction of the suprahepatic inferior vena cava (SIVC).
- Transluminal angioplasty has emerged as a potential treatment for SIVC obstruction in BCS.
- Limited case series highlight the need for further experience with this intervention.
Observation:
- Two patients with BCS due to SIVC obstruction were treated.
- The intervention involved balloon dilatation of the obstructed SIVC.
- Clinical assessments were performed during the procedure and on follow-up.
Findings:
- Transluminal angioplasty resulted in dramatic clinical improvements in both patients.
- Successful balloon dilatation led to effective control of the disease.
- Follow-up data indicated sustained positive outcomes.
Implications:
- Transluminal angioplasty is a viable and effective treatment option for BCS caused by SIVC obstruction.
- This minimally invasive approach offers significant clinical benefits and disease management.
- Further research and larger studies are warranted to confirm these findings.
Abstract:
Encouraging results of Transluminal Angioplasty for Budd-Chiari Syndrome due to obstruction of Suprahepatic inferior vena cava have been reported in the last decade. We present our experience with two such patients, treated with balloon dilatation producing dramatic clinical improvements and control of disease on follow-up.